22 May 2025 - A new drug to treat the early stages of Alzheimer’s disease has been approved for use in Australia from today.
The drug Kisunla (donanemab) is made by pharmaceutical giant Eli Lilly and already in use in countries including the US, Great Britain, China and Japan.